Literature DB >> 8709200

Uptake of duck hepatitis B virus into hepatocytes occurs by endocytosis but does not require passage of the virus through an acidic intracellular compartment.

J Köck1, E M Borst, H J Schlicht.   

Abstract

The infectious entry pathway of duck hepatitis B virus (DHBV) was investigated with primary duck hepatocytes. Virus uptake was measured by a selective PCR technique which allows for the detection of a successful infection without the need for viral replication or gene expression. To test whether DHBV uptake occurs by endocytosis, the effects of energy depletion were analyzed. The requirement for an acidic intracellular pH was tested with the lysosomotropic agent ammonium chloride. The data show that energy depletion prevents the uptake of DHBV into primary hepatocytes whereas ammonium chloride has no effect. From these data, we conclude that DHBV is taken up by its host cells by endocytosis. However, in contrast to that of most other enveloped viruses, escape of DHBV from the endocytotic route does not depend on an acidic intracellular compartment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709200      PMCID: PMC190598          DOI: 10.1128/JVI.70.9.5827-5831.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Epstein-Barr virus enters B cells and epithelial cells by different routes.

Authors:  N Miller; L M Hutt-Fletcher
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway.

Authors:  M Wittels; P G Spear
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

3.  Inhibition of duck hepatitis B virus infection by lysosomotropic agents.

Authors:  W B Offensperger; S Offensperger; E Walter; H E Blum; W Gerok
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

4.  Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.

Authors:  J Köck; H J Schlicht
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Duck hepatitis B virus infection of hepatocytes is not dependent on low pH.

Authors:  R J Rigg; H Schaller
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

Authors:  B S Stein; S D Gowda; J D Lifson; R C Penhallow; K G Bensch; E G Engleman
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

7.  HIV infection does not require endocytosis of its receptor, CD4.

Authors:  P J Maddon; J S McDougal; P R Clapham; A G Dalgleish; S Jamal; R A Weiss; R Axel
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

8.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

9.  Infectious entry pathway of influenza virus in a canine kidney cell line.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

  10 in total
  22 in total

1.  Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.

Authors:  Richard S B Milne; Anthony V Nicola; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Identification of a structural motif crucial for infectivity of hepatitis B viruses.

Authors:  Lars Stoeckl; Anneke Funk; Ariane Kopitzki; Boerries Brandenburg; Stefanie Oess; Hans Will; Hüseyin Sirma; Eberhard Hildt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

Review 3.  Intracellular transport of hepatitis B virus.

Authors:  Michael Kann; Andre Schmitz; Birgit Rabe
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling.

Authors:  Nagaraj Kerur; Mohanan Valiya Veettil; Neelam Sharma-Walia; Sathish Sadagopan; Virginie Bottero; Arun George Paul; Bala Chandran
Journal:  Virology       Date:  2010-08-01       Impact factor: 3.616

6.  A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.

Authors:  J Chojnacki; D A Anderson; E V L Grgacic
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  A metastable form of the large envelope protein of duck hepatitis B virus: low-pH release results in a transition to a hydrophobic, potentially fusogenic conformation.

Authors:  E V Grgacic; H Schaller
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Itinerary of hepatitis B viruses: delineation of restriction points critical for infectious entry.

Authors:  Anneke Funk; Mouna Mhamdi; Li Lin; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Sequences within the cytoplasmic domain of gp180/carboxypeptidase D mediate localization to the trans-Golgi network.

Authors:  F J Eng; O Varlamov; L D Fricker
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

10.  Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells.

Authors:  Anthony V Nicola; Anna M McEvoy; Stephen E Straus
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.